Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOPA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2124 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sanchez-Pernaute, R; Harvey-White, J; Cunningham, J; Bankiewicz, KS
      Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats

      MOLECULAR THERAPY
    2. Jameson, GNL; Linert, W
      The oxidation of 6-hydroxydopamine in aqueous solution. Part 2. Speciationand product distribution with iron(III) as oxidant

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2
    3. Bezard, E; Brotchie, JM; Gross, CE
      Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

      NATURE REVIEWS NEUROSCIENCE
    4. Tang, L; Frank, G
      Identification and characterization of an aromatic amino acid decarboxylase from the filarial nematode, Dirofilaria immitis

      BIOLOGICAL CHEMISTRY
    5. Hashimoto, T; Shindo, M; Yanagisawa, N
      Enhanced associated movements in the contralateral limbs elicited by briskvoluntary contraction in choreic disorders

      CLINICAL NEUROPHYSIOLOGY
    6. Hartleb, J; Arndt, R
      Cysteine and indole derivatives as markers for malignant melanoma

      JOURNAL OF CHROMATOGRAPHY B
    7. Jung, YJ; Youn, JY; Ryu, JC; Surh, YJ
      Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, inducesDNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    8. Ranasinghe, JGS; Liu, MC; Sakakibara, Y; Takeshita, Y; Fukuda, N; Nasu, T; Suiko, M
      Stereoselective and manganese-dependent sulfation and urinary excretion ofD-form and L-form meta-tyrosine O-sulfate by Sprague-Dawley rats

      JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
    9. Glasauer, FE
      Restless legs syndrome

      SPINAL CORD
    10. Hawi, Z; Foley, D; Kirley, A; McCarron, M; Fitzgerald, M; Gill, M
      Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population

      MOLECULAR PSYCHIATRY
    11. Rajput, AH
      Levodopa prolongs life expectancy and is non-toxic to substantia nigra

      PARKINSONISM & RELATED DISORDERS
    12. Nutt, JG
      Motor fluctuations and dyskinesia in Parkinson's disease

      PARKINSONISM & RELATED DISORDERS
    13. Jankovic, J; Tintner, R
      Dystonia and parkinsonism

      PARKINSONISM & RELATED DISORDERS
    14. Hwang, WJ; Calne, DB; Tsui, JKC; de la Fuente-Fernandez, R
      The long-term response to levodopa in dopa-responsive dystonia

      PARKINSONISM & RELATED DISORDERS
    15. Kuopio, AM; Marttila, RJ; Helenius, H; Rinne, UK
      Familial occurrence of Parkinson's disease in a community-based case-control study

      PARKINSONISM & RELATED DISORDERS
    16. Fredriksson, A; Schroder, N; Eriksson, P; Izquierdo, I; Archer, T
      Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits

      PARKINSONISM & RELATED DISORDERS
    17. Gasser, T; Dichgans, M; Finsterer, J; Hausmanowa-Petrusewicz, I; Jurkat-Rott, K; Klopstock, T; LeGuern, E; Lehesjoki, AE; Lehmann-Horn, F; Lynch, T; Morris, H; Rossor, M; Steinlein, OK; Wood, N; Zaremba, J; Zeviani, M; Zoharn, A
      EFNS task force on molecular diagnosis of neurologic disorders - Guidelines for the molecular diagnosis of inherited neurologic diseases - First of two parts

      EUROPEAN JOURNAL OF NEUROLOGY
    18. Dodel, RC; Berger, K; Oertel, WH
      Health-related quality of life and healthcare utilisation in patients withParkinson's disease - Impact of motor fluctuations and dyskinesias

      PHARMACOECONOMICS
    19. Rembischevski, P; Gemal, AL
      Determination of the influence of borate ion on the degradation of L-alpha-methyldopa using RP-HPLC with photodiode array detection

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    20. Harth, R; Gerlach, M; Riederer, P; Gotz, ME
      A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo

      FREE RADICAL RESEARCH
    21. Regier, JC; Mitter, C; Friedlander, TP; Peigler, RS
      Re: Phylogenetic relationships in Sphingidae (Insecta : Lepidoptera): Initial evidence from two nuclear genes

      MOLECULAR PHYLOGENETICS AND EVOLUTION
    22. Ascher, JS; Danforth, BN; Ji, SQ
      Phylogenetic utility of the major opsin in bees (Hymenoptera : apoidea): Areassessment

      MOLECULAR PHYLOGENETICS AND EVOLUTION
    23. Goto, SG; Kimura, MT
      Phylogenetic utility of mitochondrial COI and nuclear Gpdh genes in Drosophila

      MOLECULAR PHYLOGENETICS AND EVOLUTION
    24. Cools, R; Barker, RA; Sahakian, BJ; Robbins, TW
      Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

      CEREBRAL CORTEX
    25. Furlanut, M; Furlanut, M; Benetello, P
      Monitoring of L-dopa concentrations in Parkinson's disease

      PHARMACOLOGICAL RESEARCH
    26. Tamilarasu, N; Zhang, J; Hwang, S; Rana, TM
      A new strategy for site-specific protein modification: Analysis of a Tat peptide - TAR RNA interaction

      BIOCONJUGATE CHEMISTRY
    27. Zhang, FP; Bi, SP; Li, HZ; Chen, YJ; Dai, LM
      Application of L-dopa as an electroactive ligand for indirect determination of aluminum in biological samples by differential pulse voltammetry

      ELECTROANALYSIS
    28. Brown, DA
      Skin pigmentation enhancers

      JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
    29. Thobois, S; Guillouet, S; Broussolle, E
      Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    30. Bezard, E; Ravenscroft, P; Gross, CE; Crossman, AR; Brotchie, JM
      Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys

      NEUROBIOLOGY OF DISEASE
    31. Gillings, NM; Bender, D; Falborg, L; Marthi, K; Munk, OL; Cumming, P
      Kinetics of the metabolism of four PET radioligands in living minipigs

      NUCLEAR MEDICINE AND BIOLOGY
    32. Schwarz, EJ; Reger, RL; Alexander, GM; Class, R; Azizi, SA; Prockop, DJ
      Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro

      GENE THERAPY
    33. Weller, J; Sun, GC; Zhou, BH; Lan, Q; Hiruma, K; Riddiford, LM
      Isolation and developmental expression of two nuclear receptors, MHR4 and beta FTZ-F1, in the tobacco hornworm, Manduca sexta

      INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    34. Zhao, XL; Smartt, CT; Li, JY; Christensen, BM
      Aedes aegypti peroxidase gene characterization and developmental expression

      INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    35. Johnson, JK; Li, J; Christensen, BM
      Cloning and characterization of a dopachrome conversion enzyme from the yellow fever mosquito, Aedes aegypti

      INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
    36. Bertoldi, M; Voltattorni, CB
      Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidativedeaminase activities toward serotonin (5-hydroxytryptamine)

      PROTEIN SCIENCE
    37. Burzio, LA; Waite, JH
      Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking

      PROTEIN SCIENCE
    38. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
      Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?

      NEUROREPORT
    39. Ferger, B; Rose, S; Jenner, A; Halliwell, B; Jenner, P
      6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum

      NEUROREPORT
    40. Love, S
      Damage to nuclear DNA in Lewy body disease

      NEUROREPORT
    41. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
      GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets

      EUROPEAN JOURNAL OF NEUROSCIENCE
    42. Grant, S; Patel, NN; Philp, AR; Grey, CNB; Lucas, RD; Foster, RG; Bowmaker, JK; Jeffery, G
      Rod photopigment deficits in albinos are specific to mammals and arise during retinal development

      VISUAL NEUROSCIENCE
    43. Shen, B; Samaraweera, P; Rosenberg, B; Orlow, SJ
      Ocular albinism type 1: More than meets the eye

      PIGMENT CELL RESEARCH
    44. Purrello, M; Scalia, M; Corsaro, C; Di Pietro, C; Piro, S; Sichel, G
      Melanosynthesis, differentiation, and apoptosis in Kupffer cells from Ranaesculenta

      PIGMENT CELL RESEARCH
    45. Pattison, DI; Davies, MJ; Levina, A; Dixon, NE; Lay, PA
      Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: Relevance to chromium genotoxicity

      CHEMICAL RESEARCH IN TOXICOLOGY
    46. Kato, Y; Kitamoto, N; Kawai, Y; Osawa, T
      The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine

      FREE RADICAL BIOLOGY AND MEDICINE
    47. Jung, YJ; Surh, YJ
      Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid

      FREE RADICAL BIOLOGY AND MEDICINE
    48. Marin, C; Jimenez, A; Bonastre, M; Vila, M; Agid, Y; Hirsch, EC; Tolosa, E
      LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in parkinsonian rats

      SYNAPSE
    49. Cumming, P; Munk, OL; Doudet, D
      Loss of metabolites from monkey striatum during PET with FDOPA

      SYNAPSE
    50. Danielsen, EH; Smith, D; Hermansen, F; Gjedde, A; Cumming, P
      Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

      SYNAPSE
    51. Ruottinen, HM; Niinivirta, M; Bergman, J; Oikonen, V; Solin, O; Eskola, O; Eronen, E; Sonninen, P; Rinne, UK
      Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging

      SYNAPSE
    52. Pinna, A; Fenu, S; Morelli, M
      Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats

      SYNAPSE
    53. Spivak, B; Vered, Y; Yoran-Hegesh, R; Graff, E; Averbuch, E; Vinokurow, S; Weizman, A; Mester, R
      The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    54. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    55. Walters, AS; Winkelmann, J; Trenkwalder, C; Fry, JM; Kataria, V; Wagner, M; Sharma, R; Hening, W; Li, L
      Long-term follow-up on restless legs syndrome patients treated with opioids

      MOVEMENT DISORDERS
    56. Yee, RE; Irwin, I; Milonas, C; Stout, DB; Huang, SC; Shoghi-Jadid, K; Satyamurthy, N; Delanney, LE; Togaski, DM; Farahani, KF; Delfani, K; Janson, AM; Phelps, ME; Langston, JW; Barrio, JR
      Novel observations with FDOPA-PET imaging after early nigrostriatal damage

      MOVEMENT DISORDERS
    57. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    58. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    59. Fox, SH; Henry, B; Hill, MP; Peggs, D; Crossman, AR; Brotchie, JM
      Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan

      MOVEMENT DISORDERS
    60. Rascol, O; Arnulf, I; Paul, HPS; Brefel-Courbon, C; Vidailhet, M; Thalamas, C; Bonnet, AM; Descombes, S; Bejjani, B; Fabre, N; Montastruc, JL; Agid, Y
      Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

      MOVEMENT DISORDERS
    61. Datla, KP; Blunt, SB; Dexter, DT
      Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, inrats with partial 6-OHDA or FeCl3 nigrostriatal lesions

      MOVEMENT DISORDERS
    62. Petzinger, GM; Quik, M; Ivashina, E; Jakowec, MW; Jakubiak, M; Di Monte, D; Langston, JW
      Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate

      MOVEMENT DISORDERS
    63. Sedlakova, A; Kohut, A; Sarissky, M
      Changes of gastric lipase activity after ethanol and indomethacin administration: Influence of pretreatment with allopurinol, pentoxifylline and L-DOPA

      PHYSIOLOGICAL RESEARCH
    64. Ghaemi, M; Rudolf, J; Hilker, R; Herholz, K; Heiss, WD
      Increased pineal Fdopa uptake is related to severity of Parkinson's disease - A PET study

      JOURNAL OF PINEAL RESEARCH
    65. Friedman, J; Standaert, DG
      Dystonia and its disorders

      NEUROLOGIC CLINICS
    66. Silber, MH
      Sleep disorders

      NEUROLOGIC CLINICS
    67. Marcolino-Junior, LH; Teixeira, MFS; Pereira, AV; Fatibello, O
      Flow Injection Determination of levodopa in tablets using a solid-phase reactor containing lead(IV) dioxide immobilized

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    68. Grange, S; Holford, NHG; Guentert, TW
      A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats

      PHARMACEUTICAL RESEARCH
    69. El-Ahmady, SH; Nessler, CL
      Cellular localization of tyrosine decarboxylase expression in transgenic opium poppy and tobacco

      PLANT CELL REPORTS
    70. Zheleva, AM; Gadjeva, VG
      Spin labelled nitrosoureas and triazenes and their non-labelled clinicallyused analogues - a comparative study on their physicochemical properties and antimelanomic effects

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    71. Huang, SY; Hu, JJ; Wang, TT
      Effects of gas composition on the cell growth and L- DOPA production in the suspension culture of Stizolobium hassjoo

      JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS
    72. Jankovic, J
      Parkinson's diseasetherapy: treatment of early and late disease

      CHINESE MEDICAL JOURNAL
    73. Togasaki, DM; Tan, L; Protell, P; Di Monte, DA; Quik, M; Langston, JW
      Levodopa induces dyskinesias in normal squirrel monkeys

      ANNALS OF NEUROLOGY
    74. Berendse, HW; Booij, J; Francot, CMJE; Bergmans, PLM; Hijman, R; Stoof, JC; Wolters, EC
      Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

      ANNALS OF NEUROLOGY
    75. Hilker, R; Klein, C; Ghaemi, M; Kis, B; Strotmann, T; Ozelius, LJ; Lenz, O; Vieregge, P; Herholz, K; Heiss, WD; Pramstaller, PP
      Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene

      ANNALS OF NEUROLOGY
    76. Poulikakos, P; Vassilacopoulou, D; Fragoulis, EG
      L-DOPA decarboxylase association with membranes in mouse brain

      NEUROCHEMICAL RESEARCH
    77. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    78. Camicioli, R; Lea, E; Nutt, JG; Sexton, G; Oken, BS
      Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study

      CLINICAL NEUROPHARMACOLOGY
    79. Heikkinen, H; Nutt, JG; LeWitt, PA; Koller, WC; Gordin, A
      The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    80. Micallef-Roll, J; Rihet, P; Hasbroucq, T; Possamai, C; Blin, O
      Levodopa-induced drowsiness in healthy volunteers: Results of a choice reaction time test combined with a subjective evaluation of sedation

      CLINICAL NEUROPHARMACOLOGY
    81. Djaldetti, R; Rosmarin, V; Ziv, I; Melamed, E
      The pharmacokinetic profile of the "first ever" oral dose of levodopa in de novo patients with Parkinson's disease

      CLINICAL NEUROPHARMACOLOGY
    82. Offen, D; Panet, H; Galili-Mosberg, R; Melamed, E
      Catechol-O-methyltransferase decreases levodopa toxicity in vitro

      CLINICAL NEUROPHARMACOLOGY
    83. Augustyniak, W; Kanski, R; Kanska, M
      Synthesis of carbon-14 labeled [1-C-14]-, and [2-C-14]-L-tyrosine

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    84. Chan, PLS; Holford, NHG
      Drug treatment effects on disease progression

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    85. Hoegerle, S; Altehoefer, C; Ghanem, N; Brink, I; Moser, E; Nitzsche, E
      F-18-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    86. Dudesek, A; Roschinger, W; Muntau, AC; Seidel, J; Leupold, D; Thony, B; Blau, N
      Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency

      EUROPEAN JOURNAL OF PEDIATRICS
    87. Djaldetti, R; Melamed, E
      New therapies for Parkinson's disease

      JOURNAL OF NEUROLOGY
    88. Krystkowiak, P; Blatt, JL; Bourriez, JL; Duhamel, A; Perina, M; Kemoun, G; Blond, S; Guieu, JD; Destee, A; Defebvre, L
      Chronic bilateral pallidal stimulation and levodopa do not improve gait inthe same way in Parkinson's disease: a study using video motion analysis system

      JOURNAL OF NEUROLOGY
    89. Cakir, S; Bicer, E; Eleman, A
      Synthesis, spectroscopic and voltammetric studies of mixed-ligand copper(II) complexes of amino acids

      TRANSITION METAL CHEMISTRY
    90. Siddhuraju, P; Becker, K
      Rapid reversed-phase high performance liquid chromatographic method for the quantification of L-Dopa (L-3,4-dihydroxyphenylalanine), non-methylated and methylated tetrahydroisoquinoline compounds from Mucuna beans

      FOOD CHEMISTRY
    91. Sugaya, Y; Sasaki, Y; Goshima, Y; Kitahama, K; Kusakabe, T; Miyamae, T; Kato, T; Misu, Y
      Autoradiographic studies using L-[C-14]DOPA and L-[H-3]DOPA reveal regional NA(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS

      NEUROSCIENCE
    92. Lopez, A; Munoz, A; Guerra, MJ; Labandeira-Garcia, JL
      Mechanisms of the effects of exogenous levodopa on the dopamine-denervatedstriatum

      NEUROSCIENCE
    93. Hadi, N; Singh, S; Ahmad, A; Zaidi, R
      Strand scission in DNA induced by 5-hydroxytryptamine (Serotonin) in the presence of copper ions

      NEUROSCIENCE LETTERS
    94. Muller, T; Woitalla, D; Hauptmann, B; Fowler, B; Kuhn, W
      Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease

      NEUROSCIENCE LETTERS
    95. Itokazu, N; Yamamoto, K; Ouchi, Y; Cyong, JC
      Establishment of L-3,4-dihydroxyphenilalaninde-induced pharmacological dementia model mouse

      NEUROSCIENCE LETTERS
    96. Sastre-Coll, A; Esteban, S; Miralles, A; Zanetti, R; Garcia-Sevilla, JA
      The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo

      NEUROSCIENCE LETTERS
    97. Arai, N; Furukawa, N; Miyamae, T; Goshima, Y; Sasaki, Y; Ohshima, E; Suzuki, F; Fujita, K; Misu, Y
      DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats

      NEUROSCIENCE LETTERS
    98. Zucker, M; Weizman, A; Harel, D; Rehavi, M
      Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat substantia nigra and prefrontal cortex induced by psychotropic drugs

      NEUROPSYCHOBIOLOGY
    99. Zeng, BY; Pearce, RKB; MacKenzie, GM; Jenner, P
      Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study

      JOURNAL OF NEURAL TRANSMISSION
    100. Winogrodzka, A; Bergmans, P; Booij, J; van Royen, EA; Janssen, AGM; Wolters, EC
      [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 03:13:19